Zurueck zur Suche

Reporte zur Charge U6745AB

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

4Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
IL 2 PA 1 TX 1

VAERS 1388955

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENACTRA) · Charge U6745AB

mild
Staat
IL
Alter
18,0
Geschlecht
F
Eingang
10.06.2021
Impfdatum
09.06.2021
Beginn
10.06.2021
Tage bis Beginn
1,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Headache Injection site erythema Pruritus

Symptomtext

Patient called to report redness of apx. 1 inch in diameter at vaccination site, itching and headache. She has notified her primary care physician. Was advised to take Benadryl for itching and Tylenol for headache.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Headache
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
Hypertension
Andere Medikamente
Vitamin D, Vitamin B and Iron Supplement
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 1793491

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENACTRA) · Charge U6745AB

gering
Staat
IL
Alter
-
Geschlecht
U
Eingang
16.10.2021
Impfdatum
08.10.2021
Beginn
08.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Medication error

Symptomtext

patient accidentally received expired dose of MENACTRA vaccine with no reported AE; Initial information received on 11-Oct-2021 regarding an unsolicited valid non-serious case from a other health professional Medical Information (Reference number- 00807259). This case involves a patient (unknown demographics) who was accidentally vaccinated with the expired dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] (expired product administered). The patient's medical history, medical treatment, vaccination and family history were not provided. On 08-Oct-2021, the patient received a 0.5 ml dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE (lot U6745AB and expiry date: 06-Oct-2021) (Frequency: once) via an unknown route at an unknown administration site for prophylactic vaccination. It was an actual medication error case due to expired vaccine used (latency on same day). It was reported "Caller reported accidentally administering a MENACTRA vaccine on 08OCT2021 to a patient that expired on 06OCT2021 (2 days expired vaccine). Caller is asking about the efficacy of this vaccine and where to go from here". At time of reporting, no adverse event was reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1124389

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENACTRA) · Charge U6745AB

gering
Staat
PA
Alter
16,0
Geschlecht
M
Eingang
22.03.2021
Impfdatum
22.02.2021
Beginn
01.03.2021
Tage bis Beginn
7,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Body temperature increased Inappropriate schedule of product administration

Symptomtext

Patient vaccinated on 2/22/2021 with first dose of series and then again on 3/1/2021 with same vaccines due to an error in patient identification. Pt lives in congregate setting and issues with patient identification were multi-factorial. RN on site at the facility states that patient has denied any adverse effects from receiving vaccines at the incorrect intervals and within such a short window. Pt with documented temp of 99.8F on 3/1/2021. Patient to be continually monitored by RN in facility as well as will be followed by clinician.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Body temperature increased
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
none known
Allergien
none known
Vorherige Impfungen
-

VAERS 918173

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENACTRA) · Charge U6745AB

gering
Staat
TX
Alter
-
Geschlecht
U
Eingang
04.01.2021
Impfdatum
29.12.2020
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Wrong product administered

Symptomtext

Menactra mistakenly for HIB with no adverse event; Initial information received on 30-Dec-2020 regarding an unsolicited valid non-serious case from an other health professional. This case involves a 2 month old patient of unknown gender who was administered MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] (lot: U6745AB; expiry date 21-Oct-2021) mistakenly for HAEMOPHILUS TYPE B (HIB) VACCINE [HIB] (lot and expiry date unknown) (wrong product administered) both via unknown route in unknown administration site for prophylactic vaccination. The patient's medical history, past medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications were not reported. On 29-Dec-2020, the patient was given correct vaccine and had no reaction to the vaccine. This was an actual medication error case due to the wrong product administered (latency: same day). At the time of reporting, no adverse event was reported. No laboratory data was reported. Disclaimer: This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in directive 2001/83/ec and module VI of the good Pharmacovigilance practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-